The antiviral drug molnupiravir is conditionally recommended for patients with non-severe COVID-19 who are at highest risk of hospitalization, says a WHO Guideline Development Group of international experts in The BMJ today.
WHO recommends antiviral drug for patients with non-severe COVID-19 at highest risk of hospital admission
The antiviral drug molnupiravir is conditionally recommended for patients with non-severe COVID-19 who are at highest risk of hospitalization, says a WHO Guideline Development Group of international experts in The BMJ today.